Kane Biotech Inc. (the "Company", "Kane Biotech" or "Kane") announces today that BioStem Technologies Inc. ("BioStem"), has recently signed a Letter of Intent to acquire commercial stage products and ...
Biomind Labs remains committed to driving innovation in psychedelic-based treatments while working closely with regulators and policymakers to create a sustainable and impactful future for mental ...
The right scent has the power to uplift ... a plethora of biotech ingredients to create the ideal pH level for the fragrance, ensuring its longevity. Spray the lightweight gel-serum on the spots ...
Kelly on MSN22d
Top 15 Entrepreneurs Disrupting Their IndustriesWith her innovative approach to nail care, Ruth has captured the attention of a diverse audience, particularly young women ...
BioStem Technologies Signs Letter of Intent to Acquire Exclusive US Distribution Rights for revyveTM from ProgenaCare Global WINNIPEG, Manitoba, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc ...
WINNIPEG, Manitoba, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc ... including exclusive US distribution rights for Kane’s revyve TM Antimicrobial Wound Gel. BioStem made the announcement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback